SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-161630
Filing Date
2023-06-06
Accepted
2023-06-06 16:18:42
Documents
6
Effectiveness Date
2023-06-06

Document Format Files

Seq Description Document Type Size
1 S-8 d492716ds8.htm S-8 48283
2 EX-5.1 d492716dex51.htm EX-5.1 6623
3 EX-23.1 d492716dex231.htm EX-23.1 1610
4 EX-99.1 d492716dex991.htm EX-99.1 78315
5 EX-FILING FEES d492716dexfilingfees.htm EX-FILING FEES 15829
6 GRAPHIC g492716g0606015356973.jpg GRAPHIC 1582
  Complete submission text file 0001193125-23-161630.txt   153967
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272453 | Film No.: 23996326
SIC: 2834 Pharmaceutical Preparations